Literature DB >> 11886254

Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.

Daniela Tornese Buonamassa1, Catherine E Greer, Sabrina Capo, T S Benedict Yen, Cesira L Galeotti, Giuliano Bensi.   

Abstract

The L1 and L2 capsid proteins of animal and human papillomaviruses (HPVs) can self-assemble into virus-like particles (VLPs) that closely resemble native virions. The use of different animal models shows that VLPs can be very efficient at inducing a protective immune response. However, studies with infectious HPV virions and VLPs of different HPV types indicate that the immune response is predominantly type-specific. We have generated a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6b and HPV-16, and we have purified fully assembled VLPs banding in a cesium chloride gradient at the expected density of 1.29-1.3 mg/ml. Experimental evidence strongly indicated that the four proteins coassembled into VLPs. Western blot analysis, using anti-HPV-6 and anti-HPV-16 L1-specific monoclonal antibodies and type-specific L2 antisera, demonstrated that all four proteins copurified. Most importantly, immunoprecipitation experiments, carried out using type-specific anti-L1 monoclonals and either total yeast cell extracts or purified VLPs, confirmed the interaction and the formation of covalent disulfide bonds between the two L1 proteins. Finally, HPV-6/16 VLPs administered to mice induced conformational antibodies against both L1 protein types. These results suggest that coexpression of different capsid proteins may provide new tools for the induction of antibodies directed against multiple HPV types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886254     DOI: 10.1006/viro.2001.1289

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

Review 1.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

2.  A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection.

Authors:  Limin Yang; Aibo Xiao; Hu Wang; Xiaojuan Zhang; Yuan Zhang; Yunlong Li; Yanqiu Wei; Wenjun Liu; Chuangfu Chen
Journal:  Vaccines (Basel)       Date:  2022-01-26

3.  Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium.

Authors:  Naima G Cortes-Perez; Pascale Kharrat; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  BMC Res Notes       Date:  2009-08-24

4.  Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

Authors:  Kihyuck Kwak; Rosie Jiang; Subhashini Jagu; Joshua W Wang; Chenguang Wang; Neil D Christensen; Richard B S Roden
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

5.  The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles.

Authors:  Hyoung Jin Kim; Su Jeung Lim; Hye-Lim Kwag; Hong-Jin Kim
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.